A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

Full Title

A Phase 2, Single-arm Study of Cadonilimab and FLOT Chemotherapy in Patients with Locally Advanced, Resectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Yelena Janjigian’s office at 646-888-4286.